0 false false false false false false false false false false true false false false false false false No description of principal activity 2025-04-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 14480691 2025-04-01 2026-03-15 14480691 2026-03-15 14480691 2025-03-31 14480691 2024-04-01 2025-03-31 14480691 2025-03-31 14480691 2024-03-31 14480691 bus:Director1 2025-04-01 2026-03-15 14480691 core:WithinOneYear 2026-03-15 14480691 core:WithinOneYear 2025-03-31 14480691 bus:Micro-entities 2025-04-01 2026-03-15 14480691 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-15 14480691 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-15 14480691 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-15 14480691 bus:FullAccounts 2025-04-01 2026-03-15
COMPANY REGISTRATION NUMBER: 14480691
Allergia Ltd
Filleted Unaudited Financial Statements
15 March 2026
Allergia Ltd
Statement of Financial Position
15 March 2026
Period from
1 Apr 25 to
Year to
15 Mar 26
31 Mar 25
£
£
£
Current assets
375,130
281,039
Creditors: amounts falling due within one year
32,713
39,745
---------
---------
Net current assets
342,417
241,294
---------
---------
Total assets less current liabilities
342,417
241,294
Accruals and deferred income
9,176
10,615
---------
---------
333,241
230,679
---------
---------
Capital and reserves
333,241
230,679
---------
---------
For the period ending 15 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 23 March 2026 , and are signed on behalf of the board by:
Dr. O Tsilochristou
Director
Company registration number: 14480691
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Flat 2, Maple Building, 128 Borough High Street, London, SE1 1LB.